Drawing for BIOSENSE PLUS

USPTO serial 86078005

BIOSENSE PLUS

Reviewed by CopyMark Law Group

Reg. 4529301Status 710
Filing date
Status date
Registration date
May 13, 2014
Examiner
DUBOIS, SUSAN L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BIOSENSE PLUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura B. Siegal

39 Chestnut RoadManhasset, NY 11030UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
020Pillows having memory foam with a layer of gelSECTION 8 - CANCELLEDAug 6, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 18, 2020C8..CANCELLED SEC. 8 (6-YR)—
May 13, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 13, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 13, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 12, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 28, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 21, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 5, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 24, 2016ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 16, 2014ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 13, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 25, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 5, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 18, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 15, 2014ALIEASSIGNED TO LIE—
Jan 14, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 2014DOCKASSIGNED TO EXAMINER—
Dec 10, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 10, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 8, 2013MPMKNOTICE OF PSEUDO MARK E-MAILED—
Oct 6, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance